The fireside chat session covered EMA resourcing challenges, communication and transparency, scientific advice, patient involvement in the regulatory processes, collaboration among agencies, conditional marketing applications (MA), the role of real-world evidence (RWE) and how artificial intelligence (AI) can be useful to support product registrations.